Nefopam containing transdermal-matrix patches: Based on pressure-sensitive adhesive polymers

Pharmaceutical Technology

Volumn 30, Issue 3, 2006, Pages 146-163

  Mukherjee, Biswajit ^a   Das, Surajit ^a   Patra, Balaram ^a   Layek, Buddhadev ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVES; CONTROLLED DRUG DELIVERY; DERMATOLOGY; HYDROCHLORIC ACID; POLYMERS;

ADHESIVE POLYMERS; NEFOPAM; POLYMERIC COMPOSITION;

DRUG PRODUCTS;

ADHESIVE AGENT; DURO TAK 387 2051; DURO TAK 487 2516; DURO TAK 87 2852; EXCIPIENT; NEFOPAM; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; POLYVINYL ALCOHOL; POTASSIUM BROMIDE;

ADHESION; CADAVER; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; FOURIER TRANSFORMATION; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; MOISTURE; PAIN; PHYSICAL CHEMISTRY; POSTOPERATIVE PAIN; REVIEW; SCANNING ELECTRON MICROSCOPY; SKIN; SKIN PERMEABILITY; STRATUM CORNEUM; THICKNESS;

EID: 33748948726     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. S.K. Chandrasekaran, W. Bayne, and J.W. Shaw, "Pharmacokinetics of Drug Permeation Through Human Skin," J. Pharm. Sci. 67 (10), 1370-1374 (1978).
2. R.H. Guy, "Current Status and Future Prospects of Transdermal Drug Delivery," Pharm. Res. 13 (12), 1765-1769 (1996).
3. R.C. Heel, et al. "Nefopam: a Review of its Pharmacological Properties and Therapeutic Efficacy," Drugs 19 (4), 249-267 (1980).
4. S.N. Piper, et al. "Nefopam and Clonidine in the Prevention of Postanaesthetic Shivering," Anaesthesia 54 (7), 695-699 (1999).
5. J. Y. Fang, et al. "Passive and Iontophoretic Delivery of Three Diclofenac Salts Across Various Skin Types," Biol. Pharm. Bull. 23 (11), 1357-1362 (2000).
6. T.M. Goulding, Handbook of Adhesive Technology (Marcel Dekker, New York, NY, 1994), pp. 549-564.
7. B. Mukherjee, et al. "A Comparison Between Povidone Ethyl Cellulose and Povidone Eudragit Transdermal Dexamethasone Matrix Patches based on In Vitro Skin Permeation," Eur. J. Pharm. Biopharm. 59 (3), 475-483 (2005).
8. P. Arora and B. Mukherjee, "Design, Development, Physicochemical, and In vitro Evaluation of Transdermal Patches Containing Didofenac Diethylamine," J. Pharm. Sci. 91 (9), 2076-2089 (2002).
9. B. Mukherjee et al. "Sorbitan Monolaurate 20 as a Potential Skin Permeation Enhancer in Trandermal Patches," J. Appl. Res. 5(1), 96-108 (2005).
10. N.S. Thomas and R. Panchagnula, "Transdermal Delivery of Zidovudine: Effect of Vehicles on Permeation Across Rat Skin and their Mechanism of Action," Eur. J. Pharm. Sci. 18 (1), 71-79 (2003).
11. Y.W. Chien, Transdermal Therapeutic System in Controlled Drug Delivery: Fundmentals and Applications, J.R. Robinson and V.H.L. Lee, Eds. (Marcel Dekker, New York, NY, 1987), pp. 524-552.
12. R. Gupta and B. Mukherjee, "Development and In Vitro Evaluation of Diltiazem Hydrochloride Transdermal Patches Based on Povidone-Ethylcellulose Matrices," Drug. Dev. Ind. Pharm. 29 (1), 1-7 (2003).
13. K. Devi and K.L.K. Paranjothy, "Pharmacokinetic Profile of a New Matrix-Type Transdermal Delivery System: Diclofenac Diethylamonium Patch," Drug. Dev. Ind. Pharm. 25 (5), 695-700 (1999).
14. M. Guyot and F. Fawaz, "Design and In Vitro Evaluation of Adhesive Matrix for Transdermal Delivery of Propranolol," Int. J. Pharm. 204 (1-2), 71-182 (2000).
15. A.V. Pocius, "Adhesives," in Kirk-Othmer Encyclopedia of Chemical Technology, M. Howe-Grants Ed. (Wiley-Interscience, New York, NY 1991), pp. 445-466.
16. D. Satas, "Medical Products" in Handbook of Pressure Sensitive Adhesive Technology (Warwick, Rhode Island, 1999), pp. 706-723.
17. G.T. Burger and C. Miller, In Principles and Methods of Technology. Wallace Hayes A, Ed. (Raven Press, New York, NY, 1989), pp. 521-570.
18. P.P. Sarpotdar, J.L. Gaskill, and R.P. Giannini, "Effect of Polyethylene Glycol 400 on the Penetration of Drug Through Human Cadaver Skin In Vitro" J. Pharm. Sci. 75 (1), 26-28 (1986).
19. M.H. Levy, S.M. Rosen, and P. Kedzeira, "Transdermal Fentanyl: Seeding Trial in Patients with Chronic Cancer Pain," J. Pain. Symptom. Manage. 7 (suppl.), S48-50 (1992).
20. P.T. Tayade and R.D. Kale, "Encapsulation of Water-Insoluble Drug by a Cross-Linking Technique: Effect of Process and Formulation Variables on Encapsulation Efficiency, Particle Size, and In Vitro Dissolution Rate," AAPS Pharm Sci. 6(1), E12 (2004).
21. C. Kotting and K. Gerwert, "Monitoring Protein-Ligand Interactions by Time-Resolved FTIR Difference Spectroscopy," Methods. Mol. Biol. 305, 261-86 (2005).
22. G.A. Gonzalez Novoa, et al. "Physical Solid-State Properties and Dissolution of Sustained Release Matrices and Dissolution of Polyvinylacetate," Eur. J. Pharm. Biopharm. 59 (2), 343-350 (2005).
23. P. Crowley and L. Martini, "Drug-Excipient Interactions," Pharm. Tech. Eur. 13 (3), 26-34 (2001).
24. A. Barroug, et al. "Interactions of Cisplatin with Calcium Phosphate Nanoparticles: In Vitro Control Adsorption and Release," J. Orthop. Res. 22 (4), 703-708 (2004).
25. M. Miyajima, et al. "Effect of Polymer-Basic Drug Interactions on the Two Stage Diffusion-Controlled Release from a Poly(L-lactic Acid) Matrix," J. Controlled Release 61 (3), 295-304 (1999).
26. R.K. Verma and S. Garg, "Selection of Excipients for Extended Release Formulations of Glipizide Through Drug-Excipient Compatibility Testing," J. Pharm. Biomed. Anal. 38 (4), 633-644 (2005).
27. M.J. Akers, J.L. Lach, and L.J. Fischi, "Alteration of the Absorption of Dicumarol by Various Excipient Materials," J. Pharm. Sci. 62 (3), 391-395 (1973).